Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofu...
Continue reading
We are delighted that IAM has recognised seven of our partners as Strategy 300 Global Leaders—some again, others for the first time:
Continue reading
When developing high-tech technologies for use in defense and military applications, you might wonder whether patent protection is necessary. Even though your customer base is...
Continue reading
For more awards and information, click here.
